KINESITHERAPIE SMEETS
ActiveSummary
KINESITHERAPIE SMEETS has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €71k and a net result of €25k. Equity is growing by ~50.6% per year across the filed fiscal years. Its solvency ranks better than 77% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+10
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity ample (current ratio 5.22 against 1.77 in 2024; short-term debt: 14% and cash: 69.5% of total assets), and 14% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
86%
Return on assets
29.9%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filingsDeviation from the deadline
2025
20 d late
2024
11 d late
2023
28 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€71k▲ 50.4%
2024 · €47k
2023: €23k
2024: €47k
2023 → 2025
Total assets
€82k▲ 13.7%
2024 · €73k
2023: €79k
2024: €73k
2023 → 2025
Net result
€25k▼ 0.6%
2024 · €25k
2023: €21k
2024: €25k
2023 → 2025
Working capital
€49k▲ 185%
2024 · €17k
2023: €-6k
2024: €17k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€23k-€47k▲ 103%€71k▲ 50.4%
Operating result€28k-€32k▲ 16.4%€32k▼ 2.2%
Net result€21k-€25k▲ 17.9%€25k▼ 0.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 2% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €82k
Fixed assets
€22k ▼ 32.9%
Current assets
€60k ▲ 53.6%
Equity and liabilities €82k
Equity
€71k ▲ 50.4%
Debt
€12k ▼ 54.5%
Debt's share of the balance-sheet total falls from 34.9% to 14.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€44k▼
2024 · €44k
Cash flow
€37k▲
2024 · €36k
Current ratio
5.22▲
2024 · 1.77
Debt to equity
0.16▼
2024 · 0.54
ROE
34.7%▼
2024 · 52.5%
ROA
29.9%▼
2024 · 34.2%
Interest coverage
70.27▲
2024 · 35.09
Debt ≤ 1 year
€12k▼
2024 · €22k
Income taxes
€7k▲
2024 · €6k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet
Code20242025
Assets
Total assets20/58€73k€82k▲
Fixed assets21/28€33k€22k▼
Tangible fixed assets22/27€33k€22k▼
Plant, machinery and equipment23€244€620▲
Furniture and vehicles24€33k€22k▼
Current assets29/58€39k€60k▲
Amounts receivable within one year40/41-€2k
Other amounts receivable41-€2k
Cash at bank and in hand54/58€38k€57k▲
Deferred charges and accrued income490/1€697€737▲
Equity and liabilities
Total equity and liabilities10/49€73k€82k▲
Equity10/15€47k€71k▲
Contributions10/11€3k€3k=
Profit (loss) carried forward14€44k€68k▲
Amounts payable17/49€25k€12k▼
Amounts payable after more than one year17€3k-
Financial debts170/4€3k-
Amounts payable within one year42/48€22k€12k▼
Current portion of amounts payable after more than one year42€13k€3k▼
Trade debts44€1k€877▼
Suppliers440/4€1k€877▼
Taxes, remuneration and social security45€6k€7k▲
Taxes450/3€6k€7k▲
Other amounts payable47/48€2k€601▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€12k▲
Other operating charges640/8€124€295▲
Gross operating margin9900€44k€44k▼
Operating profit (loss)9901€32k€32k▼
Financial income75/76B-€55
Recurring financial income75-€55
Financial charges65/66B€1k€620▼
Recurring financial charges65€1k€620▼
Profit (loss) for the period before taxes9903€31k€31k▼
Income taxes67/77€6k€7k▲
Profit (loss) for the period9904€25k€25k▼
Profit (loss) for the period to be appropriated9905€25k€25k▼
Appropriation of the result
Profit (loss) to be appropriated9906€45k€69k▲
Profit (loss) brought forward from the previous period14P€20k€44k▲
Profit to be distributed694/7€833€859▲
Return on contributions (dividend)694€833€859▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 20 days late
2025
31-12
Financial
Liquidity triplescurrent ratio 5.22
Current ratio from 1.77 to 5.22; short-term debt falls from €22k to €12k.
11-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 11 days late
2024
31-12
Financial
Highest result since 2023net €25k ▲17.9%
Operating result €32k, net result €25k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 1.77
Current ratio from 0.85 to 1.77; short-term debt falls from €40k to €22k.
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Alken · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rijdreef 153570 AlkenGround area
954 m²
Building footprint
164 m²
Volume, LiDAR
1,083 m³
Parcel 73302E1011/00C002, Flanders · tallest building 8.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
KINESITHERAPIE SMEETS
since 20222.338.303.081
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73302E1011/00C002 | Flanders | 954 m² | 1 · 164 m² | 8.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2025 · 3 entries · 869 EUR awarded · 1,061 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 474 EUR | 474 EUR |
| 2024 | 1 | 395 EUR | 294 EUR |
| 2023 | 1 | 0 EUR | 293 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
Kinesitherapeut Wissels Michiel
BE 1009.664.783
Genk · Eq €70,986
LAMBERT FLORENT
BE 1017.683.220
Enghien · Eq €70,842
PhysioWell
BE 0794.929.747
Schaarbeek · Eq €70,829
Nicolas Barbier Kinésithérapie
BE 1008.315.097
Verlaine · Eq €70,790
AMIRI
BE 0781.710.132
Dendermonde · Eq €71,325
Of 12,686 companies in sector 86951 we hold annual accounts for 2,142. 1,927 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-11-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.